← Leaderboards
Ru-Rong Ji
Massachusetts General Hospital
$16,905,704
Attributed
$21,904,080
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,904,080 · 12
By mechanism
R01$15,350,245 · 7
RF1$2,569,851 · 1
UG3$2,079,796 · 1
R61$1,563,778 · 1
R21$238,500 · 1
R03$101,910 · 1
Top collaborators
- Charles Nicholas Serhan7 shared
- Maiken Nedergaard6 shared
- Seok-Yong Lee5 shared
- Xin Ge1 shared
- Jiyong Hong1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Raymond J Kelleher$9,450,163
- Jianren Mao$21,748,037
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainSpinal CordNerve InjuryNeuronsBehavior TestPainful NeuropathyChronic PainSpinalNeurogliaPathway InteractionsMediatingInterdisciplinary ApproachPreventAcute PainElectrophysiology (Science)Patch ClampLeadNerveCellsPlayInjuryAmericanSliceSynaptic Transmission
Grant awards (50)
Development of MMP-9 inhibitory monoclonal antibodies to relieve neuropathic pain$2,079,796
UG3 · FY2025 · NS
Developing equilibrative nucleoside transporter inhibitors as non-opioid pain therapeutics$1,563,778
R61 · FY2024 · NS
Targeting checkpoint inhibitors for pain control$2,569,851
RF1 · FY2023 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$488,534
R01 · FY2018 · DE · contact PI
Resolution pathway of pain$347,813
R01 · FY2018 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$488,534
R01 · FY2017 · DE · contact PI
Resolution pathway of pain$347,813
R01 · FY2017 · NS · contact PI
Development of novel therapeutics for pain and itch relief$159,000
R01 · FY2017 · NS
Hemichannels, astrocytic release, and neuropathic pain$388,125
R01 · FY2016 · DE · contact PI
Resolution pathway of pain$347,813
R01 · FY2016 · NS · contact PI
Treating chemotherapy-induced neuropathic pain by targeted silencing of A-fibers$238,500
R21 · FY2016 · NS · contact PI
Development of novel therapeutics for pain and itch relief$172,250
R01 · FY2016 · NS
Hemichannels, Astrocytic Release, and Neuropathic Pain$100,000
R01 · FY2016 · DE · contact PI
Neuronal and glial interactions of neuropathic pain$453,658
R01 · FY2015 · DE · contact PI
Hemichannels, astrocytic release, and neuropathic pain$388,125
R01 · FY2015 · DE · contact PI
Resolution pathway of pain$347,813
R01 · FY2015 · NS · contact PI
Development of novel therapeutics for pain and itch relief$318,000
R01 · FY2015 · NS
Neuronal and glial interactions of neuropathic pain$453,658
R01 · FY2014 · DE · contact PI
Hemichannels, astrocytic release, and neuropathic pain$388,125
R01 · FY2014 · DE · contact PI
Resolution pathway of pain$347,813
R01 · FY2014 · NS · contact PI
Development of novel therapeutics for pain and itch relief$314,334
R01 · FY2014 · NS
Resolvins, protectins, and chronic pain resolution.$451,119
R01 · FY2013 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$435,509
R01 · FY2013 · DE · contact PI
Hemichannels, astrocytic release, and neuropathic pain$372,600
R01 · FY2013 · DE · contact PI
Resolvins, protectins, and chronic pain resolution.$78,500
R01 · FY2013 · NS · contact PI
Resolvins, protectins, and chronic pain resolution.$467,038
R01 · FY2012 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$444,530
R01 · FY2012 · DE · contact PI
Hemichannels, astrocytic release, and neuropathic pain$402,375
R01 · FY2012 · DE · contact PI
Resolvins, protectins, and chronic pain resolution.$563,006
R01 · FY2011 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$406,910
R01 · FY2011 · DE · contact PI
Neuronal and glial interactions of neuropathic pain$58,832
R01 · FY2011 · DE · contact PI
Resolvins, protectins, and chronic pain resolution.$51,520
R01 · FY2011 · NS · contact PI
Resolvins, protectins, and chronic pain resolution.$615,294
R01 · FY2010 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$376,462
R01 · FY2010 · DE · contact PI
Astroglial mechanisms for inflammatory pain$355,597
R01 · FY2010 · NS · contact PI
Resolvins, protectins, and chronic pain resolution.$602,508
R01 · FY2009 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$380,265
R01 · FY2009 · DE · contact PI
Astroglial mechanisms for inflammatory pain$359,188
R01 · FY2009 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$380,265
R01 · FY2008 · DE · contact PI
Astroglial mechanisms for inflammatory pain$359,188
R01 · FY2008 · NS · contact PI
Neuronal and glial interactions of neuropathic pain$384,494
R01 · FY2007 · DE · contact PI
Astroglial mechanisms for inflammatory pain$359,188
R01 · FY2007 · NS · contact PI
The role of ERK in affective pain$30,342
R03 · FY2007 · TW · contact PI
Neuronal and glial interactions of neuropathic pain$395,977
R01 · FY2006 · DE · contact PI
The role of ERK in affective pain$31,248
R03 · FY2006 · TW · contact PI
The role of ERK in affective pain$40,320
R03 · FY2005 · TW
ERK/MAPK Activation and Pain Hypersensitivity$300,925
R01 · FY2004 · NS
ERK/MAPK Activation and Pain Hypersensitivity$300,925
R01 · FY2003 · NS
ERK/MAPK Activation and Pain Hypersensitivity$302,750
R01 · FY2002 · NS
ERK/MAPK Activation and Pain Hypersensitivity$293,872
R01 · FY2001 · NS